血糖与淋巴细胞比值与脓毒症相关急性肾损伤患者预后之间的关联
基于MIMIC-IV数据库纳入1 524例年龄≥18岁的脓毒症相关急性肾损伤(SA-AKI)患者,按GLR三分位分为GLR1组(GLR≤4.97×10-9 mmol)、GLR2组(4.97×10-9 mmol<GLR<9.75×10-9 mmol)和GLR3组(GLR≥9.75×10-9 mmol),比较28天生存与死亡组。结果显示随GLR升高,28天、90天、180天和1年死亡率均逐渐升高(均P<0.01);死亡组GLR显著高于生存组。多因素Logistic回归显示GLR是28天死亡的独立危险因素,ROC曲线AUC为0.674,与APS III评分和SOFA评分联合后AUC提高至0.806。作者认为高GLR与SA-AKI不良预后相关。
要点
- 按GLR三分位分组,GLR1、GLR2、GLR3组28天死亡率分别为11.64%、22.00%、33.86%(P<0.01)。
- GLR1、GLR2、GLR3组90天死亡率分别为15.98%、26.72%、40.55%,180天死亡率分别为17.16%、28.29%、41.73%,1年死亡率分别为17.95%、29.27%、42.72%(均P<0.01)。
- 28天死亡组GLR为9.81(5.75,20.01)×10-9 mmol,显著高于生存组的6.44(3.64,10.78)×10-9 mmol(P<0.01)。
- 多因素Logistic回归显示GLR为连续变量时OR=1.065(95%CI 1.045-1.085,P<0.001);以GLR1组为参照,GLR2组OR=1.782(95%CI 1.200-2.647,P=0.004),GLR3组OR=2.727(95%CI 1.857-4.005,P<0.001)。
- GLR预测28天死亡的AUC为0.674,最佳截断值8.769×10-9 mmol时敏感度57.1%、特异度67.1%;联合APS III评分和SOFA评分后AUC为0.806,敏感度74.6%、特异度71.4%。
适用人群与场景
- 基于MIMIC-IV数据库选取的年龄≥18岁脓毒症相关急性肾损伤(SA-AKI)患者,共1 524例,中位年龄68.28(58.96,77.24)岁,女性612例(40.16%)、男性912例(59.84%)。
诊断标准与关键阈值
- 按GLR三分位分组:GLR1组GLR≤4.97×10-9 mmol(507例),GLR2组4.97×10-9 mmol<GLR<9.75×10-9 mmol(509例),GLR3组GLR≥9.75×10-9 mmol(508例)。
- 按入院后28天是否存活分为生存组(1 181例)和死亡组(343例)。
研究设计与关键结果
- 研究类型为基于MIMIC-IV数据库的分析,纳入1 524例SA-AKI患者,按GLR三分位分组比较预后。
- 随GLR升高,28天死亡率分别为11.64%、22.00%、33.86%,90天死亡率分别为15.98%、26.72%、40.55%,180天死亡率分别为17.16%、28.29%、41.73%,1年死亡率分别为17.95%、29.27%、42.72%(均P<0.01)。
- 28天死亡组GLR为9.81(5.75,20.01)×10-9 mmol,高于生存组的6.44(3.64,10.78)×10-9 mmol(P<0.01)。
- 多因素Logistic回归显示GLR为28天死亡的独立危险因素:连续变量OR=1.065(95%CI 1.045-1.085,P<0.001);以GLR1组为参照,GLR2组OR=1.782(95%CI 1.200-2.647,P=0.004),GLR3组OR=2.727(95%CI 1.857-4.005,P<0.001)。
- ROC曲线分析显示GLR预测28天死亡的AUC为0.674,最佳截断值8.769×10-9 mmol时敏感度57.1%、特异度67.1%;GLR联合APS III评分和SOFA评分后AUC为0.806,敏感度74.6%、特异度71.4%。
证据类型、等级与局限
- 证据类型:基于MIMIC-IV数据库的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为GLR是SA-AKI患者28天死亡的独立危险因素,高GLR与SA-AKI不良预后相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the association between the glucose-to-lymphocyte ratio (GLR) and prognosis of patients with sepsis-associated acute kidney injury (SA-AKI).
METHODS: Based on the Medical Information Mart for Intensive Care-IV (MIMIC-IV), SA-AKI patients aged ≥ 18 years were selected. According to the tertiles of GLR, the patients were divided into GLR1 group (GLR ≤ 4.97×10-9 mmol), GLR2 group (4.97×10-9 mmol < GLR < 9.75×10-9 mmol) and GLR3 group (GLR ≥ 9.75×10-9 mmol). Patients with SA-AKI were divided into survival group and death group according to whether they survived 28 days after admission. The patient's gender, age, vital signs, laboratory test results, comorbidities, sequential organ failure assessment (SOFA), acute physiology score III (APS III) score and treatment measures were extracted from the database. Kaplan-Meier survival analysis was used to make the survival curves of patients with SA-AKI at 28 days, 90 days, 180 days and 1 year. Multivariate Logistic regression analysis model was used to explore the independent risk factors of 28-day mortality in patients with SA-AKI. Receiver operator characteristic curve (ROC curve) was used to analyze the predictive efficacy of GLR for the prognosis of patients with SA-AKI.
RESULTS: A total of 1 524 patients with SA-AKI were included, with a median age of 68.28 (58.96, 77.24) years old, including 612 females (40.16%) and 912 males (59.84%). There were 507 patients in the GLR1 group, 509 patients in the GLR2 group and 508 patients in the GLR3 group. There were 1 181 patients in the 28-day survival group and 343 patients in the death group. Grouping according to GLR tertiles showed that with the increase of GLR, the 28-day, 90-day, 180-day and 1-year mortality of SA-AKI patients gradually increased (28-day mortality were 11.64%, 22.00%, 33.86%, respectively; 90-day mortality were 15.98%, 26.72%, 40.55%, respectively; 180-day mortality were 17.16%, 28.29% and 41.73%, and the 1-year mortality were 17.95%, 29.27% and 42.72%, respectively, all P < 0.01). According to 28-day survival status, the GLR of the death group was significantly higher than that of the survival group [×10-9 mmol: 9.81 (5.75, 20.01) vs. 6.44 (3.64, 10.78), P < 0.01]. Multivariate Logistic regression analysis showed that GLR was an independent risk factor for 28-day mortality in patients with SA-AKI [when GLR was used as a continuous variable: odds ratio (OR) = 1.065, 95% confidence interval (95%CI) was 1.045-1.085, P < 0.001; when GLR was used as a categorical variable, compared with GLR1 group: GLR2 group OR = 1.782, 95%CI was 1.200-2.647, P = 0.004; GLR3 group OR = 2.727, 95%CI was 1.857-4.005, P < 0.001]. ROC curve analysis showed that the area under the ROC curve (AUC) of GLR for predicting 28-day mortality in patients with SA-AKI was 0.674, when the optimal cut-off value was 8.769×10-9 mmol, the sensitivity was 57.1% and the specificity was 67.1%. The predictive performance was improved when GLR was combined with APS III score and SOFA score, and the AUC was 0.806, the sensitivity was 74.6% and the specificity was 71.4%.
CONCLUSIONS: GLR is an independent risk factor of 28-day mortality in patients with SA-AKI, and high GLR is associated with poor prognosis in patients with SA-AKI.
参考来源
- Zhang L, Liu F, Li Q, et al. [Association between blood glucose-to-lymphocyte ratio and prognosis of patients with sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149387. doi:10.3760/cma.j.cn121430-20230901-00725
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。